Outcomes with reduced intensity therapy in a low-risk subset of children with National Cancer Institute (NCI) standard-risk (SR) B-lymphoblastic leukemia (B-ALL): A report from Children’s Oncology Group (COG) AALL0932.

Reuven J. Schore,Anne J. Angiolillo,John A. Kairalla,Meenakshi Devidas,Karen R. Rabin,Patrick A. Zweidler-McKay,Michael J. Borowitz,Brent L. Wood,Andrew J. Carroll,Nyla A. Heerema,Mary V. Relling,Johann Hitzler,Ashley R Lane,Kelly W. Maloney,Cindy Wang,William L. Carroll,Naomi J. Winick,Elizabeth A. Raetz,Mignon L. Loh,Stephen P. Hunger

Outcomes with reduced intensity therapy in a low-risk subset of children with National Cancer Institute (NCI) standard-risk (SR) B-lymphoblastic leukemia (B-ALL): A report from Children’s Oncology Group (COG) AALL0932.

2020

10509Background: Post-hoc analysis of COG P9904 identified a low risk (LR) group of SR B-ALL patients aged 1-9.99 years with WBC < 50,000/µL, no CNS3, and either ETV6/RUNX1 or double trisomies (DT)...

Keywords:

reduced intensity
Cog
Cancer
Oncology
b lymphoblastic leukemia
Standard Risk
Internal medicine
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations